Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting technologies, will collaborate with JSR Corporation, a materials supplier in a variety of technology driven markets, to develop human liver tissue. Through this collaboration, Aspect’s proprietary Lab-on-a-Printer 3D bioprinting platform and JSR’s advanced materials technology will be used to develop vascularized human liver lobules. “Joining forces…